Shield Therapeutics (LSE:STX) PB Ratio : 0.41 (As of May. 04, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Shield Therapeutics PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-04), Shield Therapeutics's share price is £0.0155. Shield Therapeutics's Book Value per Share for the quarter that ended in Jun. 2023 was £0.04. Hence, Shield Therapeutics's PB Ratio of today is 0.41.

The historical rank and industry rank for Shield Therapeutics's PB Ratio or its related term are showing as below:

LSE:STX' s PB Ratio Range Over the Past 10 Years
Min: 0.31 Med: 2.78 Max: 6.57
Current: 0.34

During the past 9 years, Shield Therapeutics's highest PB Ratio was 6.57. The lowest was 0.31. And the median was 2.78.

LSE:STX's PB Ratio is ranked better than
95.73% of 960 companies
in the Drug Manufacturers industry
Industry Median: 1.97 vs LSE:STX: 0.34

During the past 12 months, Shield Therapeutics's average Book Value Per Share Growth Rate was -74.00% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -57.10% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -36.50% per year.

During the past 9 years, the highest 3-Year average Book Value Per Share Growth Rate of Shield Therapeutics was -10.10% per year. The lowest was -57.10% per year. And the median was -16.75% per year.

Back to Basics: PB Ratio

Shield Therapeutics PB Ratio Historical Data

The historical data trend for Shield Therapeutics's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shield Therapeutics PB Ratio Chart

Shield Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

PB Ratio

Get a 7-Day Free Trial

0.88

6.54

2.47

2.36

3.36

Shield Therapeutics Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
PB Ratio	Get a 7-Day Free Trial													2.18	2.36	0.50	3.36	1.78

Competitive Comparison of Shield Therapeutics's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Shield Therapeutics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shield Therapeutics's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shield Therapeutics's PB Ratio distribution charts can be found below:

* The bar in red indicates where Shield Therapeutics's PB Ratio falls into.

Shield Therapeutics PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Shield Therapeutics's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Jun. 2023)
	=	0.0155	/	0.038
	=	0.41

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Shield Therapeutics (LSE:STX) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Shield Therapeutics PB Ratio Related Terms

Thank you for viewing the detailed overview of Shield Therapeutics's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Shield Therapeutics (LSE:STX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shield Therapeutics PLC (LSE:STX) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

SHIEF:USA 1JS:Germany

Address

Northern Design Centre, Baltic Business Quarter, Gateshead Quays, Newcastle, GBR, NE8 3DF

Website

https://www.shieldtherapeutics.com

Shield Therapeutics PLC is a specialty pharmaceutical company focused on the development and commercialization of late-stage, hospital-focused pharmaceuticals which address areas of high unmet medical need. The company's operating segments are based on key products including Accrufer/Feraccru, used as a novel oral treatment for iron deficiency anemia in patients, which is commercially available, and PT20 used in treating hyperphosphatemia, which is in its last stage of completion. The company generates maximum revenue from Feraccru segment.